Estrogens behave as protective agents on the development of colorectal cancer, and hormonal-replacement therapy is associated with an increased survival rate in women with this disease. Expert Review of Endocrinology and Metabolism
What do clinicians need to know in 2008? Dr. Harold Burstein brings readers up to date about trastuzumab-based regimens, selecting a chemotherapy backbone, and monitoring cardiac function. Medscape Hematology-Oncology
In this engaging Spotlight, renowned experts discuss the most up-to-date information on the treatment of patients with myelodysplastic syndrome. Medscape Hematology-Oncology
